{"id":"cyclodrine","rwe":[],"tags":[{"label":"cyclodrine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"cyclodrin","offLabel":[],"synonyms":["cyclodrine","cyclodrine hydrochloride","cyclodrin hydrochloride","cyclodrin","cyclodrine HCl","cyclodrin HCl"],"timeline":[],"approvals":[],"brandName":"Cyclodrin","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"cyclodrine","explanation":"Imagine your body's cells have locks on them, and cyclodrin is a key that fits into one of those locks. When it binds, it can either turn the lock to open the cell up to helpful signals or block the lock to prevent bad signals from getting in. However, without knowing which lock it binds to, it's hard to say exactly how it works.","oneSentence":"Cyclodrin works by interacting with a specific molecular target, although this target is currently unknown.","technicalDetail":"Cyclodrin's mechanism of action is not well understood, but it is believed to involve binding to a specific protein or receptor, potentially altering its activity or expression."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3122","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=cyclodrine","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:21:42.521117","biosimilars":[],"competitors":[],"genericName":"cyclodrine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"006638","UNII":"D1E5481T58","CHEBI":"CHEBI:135365","RXNORM":"1855092","UMLSCUI":"C0056747","PUBCHEM_CID":"162669","SECONDARY_CAS_RN":"52109-93-0","MESH_SUPPLEMENTAL_RECORD_UI":"C002864"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Cyclodrin (cyclodrine) is a small molecule drug in the cyclodrine class, but its target and mechanism of action are unknown. Its commercial status and approved indications are also unclear. As a result, key safety considerations and pharmacokinetic properties such as half-life and bioavailability are not well established. Further research is needed to fully understand cyclodrin's potential as a therapeutic agent. Its current owner and development status are also unknown.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}